Predicting recognition between T cell receptors and epitopes with TCRGP

PLoS Comput Biol. 2021 Mar 25;17(3):e1008814. doi: 10.1371/journal.pcbi.1008814. eCollection 2021 Mar.

Abstract

Adaptive immune system uses T cell receptors (TCRs) to recognize pathogens and to consequently initiate immune responses. TCRs can be sequenced from individuals and methods analyzing the specificity of the TCRs can help us better understand individuals' immune status in different disorders. For this task, we have developed TCRGP, a novel Gaussian process method that predicts if TCRs recognize specified epitopes. TCRGP can utilize the amino acid sequences of the complementarity determining regions (CDRs) from TCRα and TCRβ chains and learn which CDRs are important in recognizing different epitopes. Our comprehensive evaluation with epitope-specific TCR sequencing data shows that TCRGP achieves on average higher prediction accuracy in terms of AUROC score than existing state-of-the-art methods in epitope-specificity predictions. We also propose a novel analysis approach for combined single-cell RNA and TCRαβ (scRNA+TCRαβ) sequencing data by quantifying epitope-specific TCRs with TCRGP and identify HBV-epitope specific T cells and their transcriptomic states in hepatocellular carcinoma patients.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amino Acid Sequence
  • Complementarity Determining Regions
  • Computational Biology / methods*
  • Epitopes, T-Lymphocyte* / chemistry
  • Epitopes, T-Lymphocyte* / genetics
  • Epitopes, T-Lymphocyte* / metabolism
  • Humans
  • Normal Distribution
  • Receptors, Antigen, T-Cell* / chemistry
  • Receptors, Antigen, T-Cell* / genetics
  • Receptors, Antigen, T-Cell* / metabolism
  • Sequence Analysis, Protein / methods*

Substances

  • Complementarity Determining Regions
  • Epitopes, T-Lymphocyte
  • Receptors, Antigen, T-Cell

Grants and funding

This study was supported by Academy of Finland https://www.aka.fi/en) under grant number 314442 to SM, by 647355 (M-IMM project); H2020 European Research Council (ERC), https://erc.europa.eu to SM, by ERA PerMed (JAKSTAT-TARGET consortium) http://www.erapermed.eu to SM, by Finnish special governmental subsidy for health sciences, research and training, https://minedu.fi/en/subsidies to SM, by The Sigrid Juselius Foundation, https://sigridjuselius.fi/en to SM and by the Cancer Foundation of Finland, https://syopasaatio.fi/en to SM. HL received support under grant numbers 314445, 335436 (Terva program: Heal-Art consortium); from Academy of Finland, https://www.aka.fi/en, 311584 (Quantifying molecular networks at single-cell level), from Academy of Finland, https://www.aka.fi/en, 313271 (ICT 2023 programme: TensorMed consortium); from Academy of Finland, https://www.aka.fi/en, and from Cancer Foundation of Finland, https://syopasaatio.fi/en. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.